Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Oppenheimer Initiates Coverage On Caribou Biosciences with Outperform Rating, Announces Price Target of $36
Oppenheimer analyst Mark Breidenbach initiates coverage on Caribou Biosciences (NASDAQ:CRBU) with a Outperform rating and announces Price Target of $36.
Caribou Biosciences To Present At Jefferies Summit On Wednesday, Oct. 27 At 1 p.m. EDT, At Barclays Summit Monday, Nov. 15, 9:30 a.m. EDT
Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel Haurwitz, Ph.D., Caribou’s President and Chief Executive Officer, will
